INGN 201

· Introgen Therapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for INGN 201, covering 2007-09-11 to 2008-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer [Phase 2]

See pricing